Healthcare • Medical Devices
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if NPCE is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
17 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
113 filers reported a long position in NPCE for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Polar Capital Holdings Plc | $52.4M | 3.3M | Unchanged |
| Soleus Capital Management, L.P. | $46.3M | 2.9M | -0.7% |
| First Light Asset Management, LLC | $45.5M | 2.9M | +16.3% |
| MORGAN STANLEY | $42.2M | 2.7M | +3.4% |
| BlackRock, Inc. | $39.4M | 2.5M | +5.6% |
| ORBIMED ADVISORS LLC | $23.9M | 1.5M | -28.2% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | $23M | 1.4M | -0.3% |
| VANGUARD CAPITAL MANAGEMENT LLC | $19.5M | 1.2M | +9.2% |
| DEUTSCHE BANK AG\ | $14.9M | 938.9K | +0.7% |
| ARMISTICE CAPITAL, LLC | $11M | 692K | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.